Hematology
From the Journals
Poor-prognosis cancers linked to highest suicide risk in first year
Pancreatic and lung cancer patients had high rates of suicide in comparison to the general population, while breast and prostate cancer patients...
From the Journals
Immediate acting inhibitors complicate hemophilia A diagnosis
Researchers recommended taking a systematic approach to testing.
News
FDA approves ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria
The drug’s novel formulation means that patients can be treated every eight weeks, instead of every two weeks as is the case with the previously...
From the Journals
Survivors of childhood Hodgkin lymphoma face 14-fold risk of second cancers
The findings highlight the need to screen high-risk subgroups of cancer survivors.
Conference Coverage
GO-8: Early promise for novel FVIII variant in hemophilia A
SAN DIEGO – The data are encouraging in the first four patients treated with the single infusion.
News
FDA aims to boost safety of platelets for transfusion
The agency is seeking input on ways to decrease the risk of bacterial contamination in platelets stored for 5 and 7 days after collection.
From the Journals
In-hospital blood saving strategy appears safe with anemia
Tolerating moderate in-hospital anemia did not negatively impact readmissions or mortality over 6 months.
Daily News Podcast
Telemedicine not widely used
Brain injury in sickle cell merits more attention.
Conference Coverage
Phase 3 data support apixaban for cancer-associated VTE
The rate of major bleeding was similar with apixaban and dalteparin.
Daily News Podcast
Parental leave for residents
Social media can help you stay up-to-date: advice on how to use it.
Conference Coverage
Brain injury in sickle cell merits more attention
BETHESDA, MD – It’s time to consider the silent infarcts of sickle cell patients.